001     164200
005     20240229123207.0
024 7 _ |a 10.1007/s10654-019-00559-6
|2 doi
024 7 _ |a pmid:31564045
|2 pmid
024 7 _ |a pmc:PMC7116136
|2 pmc
024 7 _ |a 0393-2990
|2 ISSN
024 7 _ |a 1573-7284
|2 ISSN
024 7 _ |a altmetric:67474971
|2 altmetric
037 _ _ |a DKFZ-2020-02310
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Naudin, Sabine
|0 0000-0003-1049-6225
|b 0
245 _ _ |a Healthy lifestyle and the risk of pancreatic cancer in the EPIC study.
260 _ _ |a Dordrecht [u.a.]
|c 2020
|b Springer Science + Business Media B.V.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1604064542_22987
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Pancreatic cancer (PC) is a highly fatal cancer with currently limited opportunities for early detection and effective treatment. Modifiable factors may offer pathways for primary prevention. In this study, the association between the Healthy Lifestyle Index (HLI) and PC risk was examined. Within the European Prospective Investigation into Cancer and Nutrition cohort, 1113 incident PC (57% women) were diagnosed from 400,577 participants followed-up for 15 years (median). HLI scores combined smoking, alcohol intake, dietary exposure, physical activity and, in turn, overall and central adiposity using BMI (HLIBMI) and waist-to-hip ratio (WHR, HLIWHR), respectively. High values of HLI indicate adherence to healthy behaviors. Cox proportional hazard models with age as primary time variable were used to estimate PC hazard ratios (HR) and 95% confidence intervals (CI). Sensitivity analyses were performed by excluding, in turn, each factor from the HLI score. Population attributable fractions (PAF) were estimated assuming participants' shift to healthier lifestyles. The HRs for a one-standard deviation increment of HLIBMI and HLIWHR were 0.84 (95% CI: 0.79, 0.89; ptrend = 4.3e-09) and 0.77 (0.72, 0.82; ptrend = 1.7e-15), respectively. Exclusions of smoking from HLIWHR resulted in HRs of 0.88 (0.82, 0.94; ptrend = 4.9e-04). The overall PAF estimate was 19% (95% CI: 11%, 26%), and 14% (6%, 21%) when smoking was removed from the score. Adherence to a healthy lifestyle was inversely associated with PC risk, beyond the beneficial role of smoking avoidance. Public health measures targeting compliance with healthy lifestyles may have an impact on PC incidence.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 2 |a Alcohol Drinking: epidemiology
|2 MeSH
650 _ 2 |a Cohort Studies
|2 MeSH
650 _ 2 |a Exercise
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Healthy Lifestyle
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Incidence
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Nutritional Status
|2 MeSH
650 _ 2 |a Obesity: complications
|2 MeSH
650 _ 2 |a Obesity, Abdominal: complications
|2 MeSH
650 _ 2 |a Obesity, Abdominal: epidemiology
|2 MeSH
650 _ 2 |a Pancreatic Neoplasms: epidemiology
|2 MeSH
650 _ 2 |a Pancreatic Neoplasms: etiology
|2 MeSH
650 _ 2 |a Proportional Hazards Models
|2 MeSH
650 _ 2 |a Prospective Studies
|2 MeSH
650 _ 2 |a Risk Factors
|2 MeSH
650 _ 2 |a Smoking: epidemiology
|2 MeSH
650 _ 2 |a Waist-Hip Ratio
|2 MeSH
700 1 _ |a Viallon, Vivian
|b 1
700 1 _ |a Hashim, Dana
|b 2
700 1 _ |a Freisling, Heinz
|b 3
700 1 _ |a Jenab, Mazda
|b 4
700 1 _ |a Weiderpass, Elisabete
|b 5
700 1 _ |a Perrier, Flavie
|b 6
700 1 _ |a McKenzie, Fiona
|b 7
700 1 _ |a Bueno-de-Mesquita, H Bas
|b 8
700 1 _ |a Olsen, Anja
|b 9
700 1 _ |a Tjønneland, Anne
|b 10
700 1 _ |a Dahm, Christina C
|b 11
700 1 _ |a Overvad, Kim
|b 12
700 1 _ |a Mancini, Francesca R
|b 13
700 1 _ |a Rebours, Vinciane
|b 14
700 1 _ |a Boutron-Ruault, Marie-Christine
|b 15
700 1 _ |a Katzke, Verena
|0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
|b 16
|u dkfz
700 1 _ |a Kaaks, Rudolf
|0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|b 17
|u dkfz
700 1 _ |a Bergmann, Manuela
|b 18
700 1 _ |a Boeing, Heiner
|b 19
700 1 _ |a Peppa, Eleni
|b 20
700 1 _ |a Karakatsani, Anna
|b 21
700 1 _ |a Trichopoulou, Antonia
|b 22
700 1 _ |a Pala, Valeria
|b 23
700 1 _ |a Masala, Giovana
|b 24
700 1 _ |a Panico, Salvatore
|b 25
700 1 _ |a Tumino, Rosario
|b 26
700 1 _ |a Sacerdote, Carlotta
|b 27
700 1 _ |a May, Anne M
|b 28
700 1 _ |a van Gils, Carla H
|b 29
700 1 _ |a Rylander, Charlotta
|b 30
700 1 _ |a Borch, Kristin Benjaminsen
|b 31
700 1 _ |a Chirlaque López, María Dolores
|b 32
700 1 _ |a Sánchez, Maria-Jose
|b 33
700 1 _ |a Ardanaz, Eva
|b 34
700 1 _ |a Quirós, José Ramón
|b 35
700 1 _ |a Amiano Exezarreta, Pilar
|b 36
700 1 _ |a Sund, Malin
|b 37
700 1 _ |a Drake, Isabel
|b 38
700 1 _ |a Regnér, Sara
|b 39
700 1 _ |a Travis, Ruth C
|b 40
700 1 _ |a Wareham, Nick
|b 41
700 1 _ |a Aune, Dagfinn
|b 42
700 1 _ |a Riboli, Elio
|b 43
700 1 _ |a Gunter, Marc J
|b 44
700 1 _ |a Duell, Eric J
|b 45
700 1 _ |a Brennan, Paul
|b 46
700 1 _ |a Ferrari, Pietro
|b 47
773 _ _ |a 10.1007/s10654-019-00559-6
|g Vol. 35, no. 10, p. 975 - 986
|0 PERI:(DE-600)2004992-4
|n 10
|p 975 - 986
|t European journal of epidemiology
|v 35
|y 2020
|x 1573-7284
909 C O |o oai:inrepo02.dkfz.de:164200
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 16
|6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 17
|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2020
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2020-01-23
|w ger
915 _ _ |a National-Konsortium
|0 StatID:(DE-HGF)0430
|2 StatID
|d 2020-01-23
|w ger
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2020-01-23
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EUR J EPIDEMIOL : 2018
|d 2020-01-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2020-01-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2020-01-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
|d 2020-01-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2020-01-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2020-01-23
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
|d 2020-01-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2020-01-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2020-01-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2020-01-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2020-01-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2020-01-23
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b EUR J EPIDEMIOL : 2018
|d 2020-01-23
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21